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The resemblance of the mammalian fetus to a homograft has raised the ques- 
tion as to why it is not rejected by the mother in the manner of a homograft. 
That portion of the fetus' genetic makeup which is derived from the father 
should afford sufficient histoincompatibility to evoke an immunologic response 
in the mother. It was at one time suggested that the onset of labor might result 
from the development of maternal homograft immunity against her fetuses, 
with their subsequent rejection. There are, however, various objections to this 
concept. For example, strains of animals inbred to the point of histocompati- 
bility would on this basis be incapable of delivering their young, but no differ- 
ences in gestation time have occurred in highly inbred strains of mice. In ad- 
clifton, various studies both in animals (1-3) and man (4) have not only failed 
to demonstrate the appearance of maternal homograft sensitization against the 
fetuses but on the contrary have shown that a degree of tolerance to paternal 
strain tissues may develop in the mother as a result of one or more pregnancies. 
Although homograft sensitization of the mother does not appear  to occur 
naturally, the mother can be experimentally sensitized against her fetuses. A 
degree  of incompatibility can be achieved by grafts made before pregnancy 
from a prospective father to the mother, and subsequent transplants of tissue 
from the fetuses or offspring to the mother show the anticipated accelerated re- 
jection (5). Despite such maternal sensitization, apparently normal pregnancies 
are  possible.  More recently, we have  carried  out experiments  (6)  in  which, 
by using transplanted eggs,  sensitization of a  mother against both maternal 
and paternal components of the fetus' genetic makeup can be achieved. Under 
these conditions also, apparently normal young are born after a normal gesta- 
tion time. Studies of this type demonstrate that a normal pregnancy is possible 
in the face of maternal sensitization against her fetuses. They do not, however, 
reveal whether some of the fetuses had been destroyed, leaving as survivors 
only a selected population of perhaps less incompatible fetuses. We have there- 
fore carried out a  series  of experiments in which a  rabbit  sensitized by skin 
grafts against both members of one breeding pair was later simultaneously im- 
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planted with two kinds of eggs. One kind was derived from the sensitizing pair 
and the other from a  second breeding pair against which no sensitization had 
been induced. We then compared the number of young born in the same preg- 
nancy of each kind of egg. The results show that survival rates for the 2 kinds 
of eggs were almost identical, indicating that maternal sensitization against the 
fetuses did not demonstrably harm them. 
Methods 
Fertilized rabbit eggs were transplanted from each of two breeding pairs of rabbits to a re- 
cipient female previously sensitized against one breeding pair but not the other. The recipient 
female received  ear skin homografts at monthly intervals from both members of one breeding 
pair at least 3 times before egg transplantation, again at the time of transplantation, and 
again in midpregnancy. TecI~niques of grafting and egg transplantation have been previously 
described  (6). 
Both members of one of the egg donor pairs were New Zealand whites and of the other, 
chinchillas. The breed used as skin graft donors in a given family was selected by random num- 
bers. The breed of the recipient rabbit was similarly  randomized. And because the in vitro hold- 
ing time of the eggs might influence their survival, the order in which eggs were flushed from 
the 2 donors (sensitizing and non-sensitizing) was randomized in such a way that there were 
equal numbers of each handled in each way. Equal numbers of eggs up to 10 from each donor 
were obtained and mixed together in 2 lots in such a way that half from each donor was washed 
into each of the recipient's fallopian tubes. The number of young subsequently born of eggs de- 
rived from each breeding pair was then counted; the two types of offspring were distinguish- 
able by hair and skin color. 
Testing to show that grafts from an egg donor pair sensitized the recipient mother against 
the transplanted fetuses have been previously reported (6). Similar tests were carried out in 
one family (family 3) in the present series. After the birth of young, grafts from the egg donor 
pair were once again applied to the recipient mother, and at the height of rejection, a graft 
from an offspring born of one of their transplanted eggs was made to the recipient mother. A 
similar graft from a simultaneously  born young derived from an egg of the non-sensitizing  pair 
was used as a control; grafts from both kinds of offspring to an unrelated, ungrafted female 
served as additional controls. White graft rejection was taken as indication of preexisting sensi- 
tization. White graft rejection is both more rapid and qualitatively different from either first 
or second set rejection. 
RESULTS 
Sixteen female rabbits  received a double implant of rabbit  eggs (Table I). 
Of these, II successfully  delivered  living  young. One more died of unknown 
cause on day 29 of  pregnancy (normal term: 30 to  32 days) and at autopsy had 
2 apparently normal term fetuses  (one from each of the 2 kinds of eggs) which 
have been included in the study. The total number of eggs implanted in the 16 
rabbits was 274; one-half of these was from the sensitizing donors and one-half 
from the non-sensitizing. Thirty-four babies of the former  (24.8 per cent) and 
31 of the latter (22.6 per cent) were carried to term. These percentages are not 
significantly different. 
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and those flushed from the second donor for 15 to 50 minutes. To evaluate the 
effect of the longer in vitro holding period on survival, the  experiments have 
been sorted into 2 groups  (Table II), depending upon whether  the sensitizing 
or non-sensitizing doe was flushed first. In each series, survival rates were some- 
what lower for the eggs held for a  longer time in vitro. 
TABLE I 
Survival Rates of Fetuses from Transplanted Ova 
Family 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Eggs flushed 
first 
S 
S 
S 
NS 
NS 
S 
NS 
S 
S 
S 
NS 
NS 
NS 
S 
NS 
NS 
No. of eggs transplanted  No. of babies born 
s  NS 
8  8 
10  10 
10  10 
10  10 
10  10 
8  8 
10  10 
10  10 
10  10 
6  6 
9  9 
10  10 
7  7 
8  8 
2  2 
9  9 
137  137 
NS 
3  5 
2  7 
1  4 
0  0 
1"  1" 
5  2 
2  3 
0  0 
2  0 
2  2 
0  0 
8  2 
0  0 
3  1 
1  1 
4  3 
total  S: 8  34  31 
NS: 8 
Survival rate, per cent  24.8  22.6 
S, sensitizing donor; NS, non-sensitizing donor. 
The egg recipient mother had been  homograft-sensitized  against one breeding pair (S) 
but not against a second pair (NS).  Equal numbers of fertilized eggs from  each pair were 
implanted into the same female at the same operation. Survival rates were not significantly 
different for the 2 kinds of fetuses. 
* Mother died on day 29; 2 apparently normal term fetuses found at autopsy. 
The  results of grafting in family 3  to demonstrate  sensitization of the egg 
recipient mother against her offspring are shown in Table III. A  graft to the 
mother from a baby rabbit derived from the sensitizing pair was rejected in the 
time and manner of a  white graft; a  similar graft from a  baby derived from the 
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were the grafts from the 2  babies  to a  control female. The pattern  of rejection 
indicates  that  the egg recipient mother  bore homograft  sensitivity specifically 
against young derived from the sensitizing pair and not against  young carried 
in the same pregnancy but derived from the non-sensitizing pair. 
TABLE II 
Survival Rates of Fetuses from Transplanted Ova 
nsitizing donor flushed first 
Families 
1, 2, 3, 6, 8, 9, 
10,  14 
rvival rate, per cent 
m-sensitizing donor flushed  4, 5, 7,  11,  12, 
first  13,  15,  16 
rvival rate, per cent 
Total No. of eggs 
transplanted 
S 
70 
67 
NS 
70 
67 
Total No. of 
babies born 
S  NS 
18  21 
25.7  30,0 
16  10 
23.9  14.9 
S, sensitizing donor; NS, non-sensitizing donor. 
The 16 experiments have been separated into 2 groups depending on whether eggs were 
flushed first from the sensitizing or non-sensitizing donor. The earlier flushing resulted in a 
longer in vitro holding time as compared to eggs later flushed from the second donor. Both 
kinds of eggs were implanted into the recipient at the same time. The longer in vitro holding 
period appeared to impair survival of the eggs. 
TABLE III 
Graft Survival Time 
Graft donor  Graft recipient  Graft survival time 
S baby 
S baby 
NS baby 
NS baby 
Egg-recipient mother 
Unrelated control 
Egg-recipient mother 
Unrelated control 
days 
5* 
7 
S, sensitizing donor; NS, non-sensitizing donor. 
Survival times of skin homografts from offspring to the egg-recipient mother and  to  a 
control female. The graft from the baby born of an egg from the sensitizing donor was rejected 
by the egg-recipient mother in the time and manner of a white graft, indicating a preexisting 
sensitization. All other grafts were rejected in the time and manner of first set grafts. In our 
experience (6), survival time of first set grafts (in days) was 7.9, a  =  1.9, range  =  6 to  14. 
Homograft sensitivity in the mother was therefore directed specifically against the offspring 
derived from the sensitizing donor. 
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DISCUSSION 
The present studies show once again under more critical conditions that the 
fetus which is the object of maternal homograft sensitization is in some way 
protected. The means by which such protection is afforded has become partially 
clarified. In a  previous discussion (6),  evidence was reviewed suggesting that 
neither an antigenic immaturity of the fetus (as distinct from the placenta) 
nor a  reduced immunologic responsiveness of the mother was a  likely possi- 
bility. The protective mechanism appeared  to lie in the physical separation 
of the mother and fetus afforded by an intact placenta and in the special prop- 
erties  of  the  trophoblast.  Several  observations  on  the  effectiveness  of  the 
placental barrier and pertinent to the homotransplantation problem are now 
available. The transfer of white cells from mother to fetus has been studied by 
Desai and Creger (7). Using atabrine-labeled maternal cells, they demonstrated 
at term only the occasional transfer of granulocytes, lymphocytes, and platelets 
from mother to fetus. The rarity with which labeled cells were found in fetal 
blood indicated the effectiveness of the placental barrier at term. Of the cells 
transferred,  only the lymphocyte is known to have  the potential of further 
division and colonization of the fetus. It would be of interest to extend these 
studies back to earlier fetal life. The human fetus at term probably has sufficient 
immunologic maturity to destroy invading maternal leukocytes. But earlier, 
during the period of immunologic tolerance, (a period not precisely defined in 
the human fetus), colonization by invading maternal lymphocytes should be 
possible. This would presumably be followed by runting (8)  and either fetal 
death with abortion or perhaps by disease now unrecognized and lost in the ill- 
defined group classed as dysmature infants. Whether or not the mammalian 
fetus is wholly protected against this eventuality is not known. 
The placenta has been exposed experimentally to certain agents (hyaluroni- 
dase, reference 9 and x-radiation, reference 10)  thought to damage it and to 
impair its etTectiveness as a barrier. With an appropriate adjustment of dosage 
of the presumably noxious agents,  the fetuses were not destroyed, but after 
birth, the young showed a degree of tolerance to maternal skin homografts as 
evidence of immunologic contact with the mother in utero. Damage to the young 
was also apparent, though whether attributable to immunologic contact or the 
primary noxious agent was not certain. 
Also of interest is the effectiveness of the placenta in preventing transfer of 
those circulating factors appearing in response to homografting and possibly 
playing a role in homograft rejection. These have been variously recognized (11) 
as hemolysins, leukoagglutinins, and cytotoxic and tumor protective antibodies, 
and of these, cytotoxic antibodies appear to be implicated in homograft rejec- 
tion. Kaliss and coworkers (12) have recently found in mice that the growth of a 
tumor used to immunize a female during pregnancy was enhanced in her off- 
spring. Enhancement appears to reflect the presence of a circulating antibody, 786  HOMOGRAFT  IMMUNITY  IN  PREGNANCY 
in this case  transmitted from mother to offspring. Boyse (13)  has suggested 
that enhancement results when the antigenic stimulus of a graft is blunted by 
the presence in the host of passively transferred cytotoxic antibody. The latter 
may be present at levels incapable of destroying the challenging graft, but none 
the less impairing the host's ability to respond with cytotoxic antibody pro- 
duction. Kaliss' observations on tumor growth do not show what would occur 
if maternal antibody was directed against the fetus, although neither homol- 
ogous nor isohemolytic disease has as yet been recognized in mice.  Using  a 
test for cytotoxic antibody, we are presently studying this problem in rabbits. 
The means by which the placenta itself is protected against maternal im- 
munity appears  to require  special properties  of the trophoblast.  It has been 
suggested that this tissue, which is  in direct contact with the mother, lacks 
homotransplantation antigens. The suggestion affords an adequate explanation 
of placental histocompatibility but is as yet without experimental support. On 
the contrary, 2 studies suggest that the trophoblast does have at least a degree 
of antigenic potency. Hulka (14)  demonstrated that a  globulin appearing in 
postpartum  maternal  sera  was  bound  by  cytoplasmic elements  of the  syn- 
cytiotrophoblast. He thought that production of antibody during pregnancy 
was masked by its continuous absorption and removal by the placenta. Douglas 
(15)  was able to produce a  typical lupus preparation by using the serum and 
polymorphonuclear cells from a patient with disseminated lupus erythematosis 
against the trophoblastic cells of the patient's own fetus. He concluded that 
nuclear material of the syncytiotrophoblast was antigenic. While the interpreta- 
tion of these two experiments is open to some question, they at least raise doubt 
as to the suggested lack of antigenicity of the trophoblast. 
We have found a  lower survival rate of eggs  transplanted after being held 
in vitro for a longer time. In our first 3 experiments we had overlooked this pos- 
sibility. At that time, the systematic selection of the sensitizing donor to flush 
first yielded results initially suggesting a harmful effect of homograft sensitiza- 
tion on fetal survival. We became aware of the defect in our experimental de- 
sign  on reading  an  article by Menge and  coworkers  (16),  who encountered 
sharply falling survival rates with increasing time of in vitro holding. Subse- 
quently in our work, randomization was carried out in a manner to correct for 
the initial disparity in the order of flushing eggs from the donors, and the final 
survival rates for the two types of eggs were virtually identical. 
SUMMARY 
The effect of homograft sensitization of a mother against her fetuses has been 
studied. A female rabbit was repeatedly grafted from both members of a breed- 
ing pair. Their offspring should and do become objects of homograft sensitiza- 
tion induced in the female by grafts from the parents. After sensitization was JONATHAN T.  LAN~£AN, LLEWELLYN  HEROD, AND  SENIH FIKRIG  787 
established,  fertilized ova were  transplanted  from  the  breeding  pair  to  the 
sensitized female. At the same operation, an equal number of eggs was also 
transplanted to the same recipient from another breeding pair against which 
no sensitization had been induced. In  16 such families, the survival rates for 
offspring born of each type of egg were found to be almost identical, indicating 
that homograft sensitization in the mother directed against her fetuses did not 
demonstrably  harm  them. 
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